Conventional and advanced imaging in neuromyelitis optica

Y Barnett1, I J Sutton2, M Ghadiri3

  • 1From the Sydney Neuroimaging Analysis Centre (Y.B., M.H.B.), Sydney, AustraliaBrain and Mind Research Institute (Y.B., M.G., L.M., M.H.B.), University of Sydney, Sydney, AustraliaDepartment of Medical Imaging and Neurology (Y.B., I.J.S.), St Vincent's Hospital, Sydney, Australia.

Summary

Differentiating neuromyelitis optica from multiple sclerosis is crucial for treatment. Aquaporin 4 antibodies are key to neuromyelitis optica, requiring specific early, aggressive immunosuppression for better outcomes.